Year All20232022202120202019 Sep 26, 2023 Verve to Present Interim Data from the heart-1 Phase 1b Clinical Trial of VERVE-101 in HeFH Patients at the American Heart Association’s Scientific Sessions 2023 Sep 21, 2023 Verve Therapeutics to Participate in the 2023 Cantor Global Healthcare Conference Sep 18, 2023 Verve Expands Leadership Team with Appointment of Frederick T. Fiedorek, M.D., as Chief Medical Officer Aug 10, 2023 Verve Therapeutics Highlights Recent Company Progress and Reports Second Quarter 2023 Financial Results Aug 03, 2023 Verve Therapeutics to Present at the Canaccord 43rd Annual Growth Conference Jun 15, 2023 Verve Establishes Global Collaboration with Lilly to Advance Verve’s In Vivo Gene Editing Program Targeting Lp(a) for the Treatment of Atherosclerotic Cardiovascular Disease Jun 01, 2023 Verve Therapeutics to Participate in the 2023 Jefferies Healthcare Conference May 23, 2023 Verve Therapeutics to Participate in the Stifel 2023 Tailoring Genes: Virtual Genetic Medicines Day May 15, 2023 Verve Therapeutics Announces Pipeline Progress and Expansion and Reports First Quarter 2023 Financial Results May 09, 2023 Verve Therapeutics to Participate in the RBC Capital Markets 2023 Global Healthcare Conference
Sep 26, 2023 Verve to Present Interim Data from the heart-1 Phase 1b Clinical Trial of VERVE-101 in HeFH Patients at the American Heart Association’s Scientific Sessions 2023
Sep 18, 2023 Verve Expands Leadership Team with Appointment of Frederick T. Fiedorek, M.D., as Chief Medical Officer
Aug 10, 2023 Verve Therapeutics Highlights Recent Company Progress and Reports Second Quarter 2023 Financial Results
Jun 15, 2023 Verve Establishes Global Collaboration with Lilly to Advance Verve’s In Vivo Gene Editing Program Targeting Lp(a) for the Treatment of Atherosclerotic Cardiovascular Disease
May 23, 2023 Verve Therapeutics to Participate in the Stifel 2023 Tailoring Genes: Virtual Genetic Medicines Day
May 15, 2023 Verve Therapeutics Announces Pipeline Progress and Expansion and Reports First Quarter 2023 Financial Results
May 09, 2023 Verve Therapeutics to Participate in the RBC Capital Markets 2023 Global Healthcare Conference
